Data from Induction of Anti-Glioma Natural Killer Cell Response following Multiple Low-Dose Intracerebral CpG Therapy
Darya Alizadeh(CTI BioPharma (United Kingdom)), Behnam Badie(City Of Hope National Medical Center), Omar Farrukh(City Of Hope National Medical Center), Christine E. Brown(City Of Hope National Medical Center), Michael C. Jensen(Seattle Children's Hospital), Leying Zhang(City Of Hope National Medical Center)
Cited by 0
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
|Blood|2017|1.1k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754